|
|
|
|
Nucleoside reverse transcriptase inhibitors (NRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Nucleoside reverse transcriptase inhibitors (NRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library Nucleoside reverse transcriptase inhibitors (NRTIs) for HIV - [Medication] - Quest Diagnostics Patient Health Library Immune system,...
|
|
|
Treatment of HIV Disease: The Importance of Drug-Drug Interactions
- - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
author: BioPortfolio - Knowledge Management, Market Analysis and Market Research
|
|
|
Approved Products_2004.xls
194 Jul- 02 Aranes p hyperglycosylated erythropoietin Chemotherapy- induced anemia Amgen 195 Jul- 02 X yrem Sodium oxybate oral solution Cataplexy associated with narcolepsy Orphan Medical 196 Au g- 02 Prestara Prasterone Lupus Genelabs 197 Se p- 02 Hepsera Adefovir dipivoxil Chronic Hepatitus B Gilead 198 Nov- 02 Mitoz ytrex Generic mitomycin Disseminated adenocarcinoma of the...
author: Reijer
|
|
|
Approved Products_2004.xls page 5
author: Reijer
|
|
|
Database E
E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
|
|
|
http://www.biotechnav.com/1-04NewsColorBlank.pdf
Emtricitabine was approved in 2003 and is marketed as Emtriva for use in combination with other antiretrovirals for the treatment of HIV infection in the U
The next step for Gilead is to seek a new FDA- approved indication for Emtriva, using the Phase II data as a single pivotal trial for treating chronic hepatitis B infections
Also Gilead could develop a co-...
|
|
|
http://www.biotechnav.com/1-04NewsColorBlank.pdf page 10
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
|
|
|
NDA Approvals for Calendar Year 2003
NDA APPROVALS FOR CALENDAR YEAR 2003 Updated through December 31, 2003 NDA NUMBER DRUG NAME GENERIC NAME APPLICANT/ SPONSOR CHEMICAL TYPE THERAPEUTIC CLASS APPROVAL DATE - 21434 Xanax XR Alprazolam Pharmacia and Upjohn FR 3 S 17-Jan-03 21305 Sodium Iodide I-131 Sodium Iodide I-131 DraxImage 3,5 S 24-Jan-03 20414 Pyridostigmine Bromide Pyridostigmine Bromide US Army 3 P 05-Feb-03...
author: Susan Daugherty
|
|
|
HIV GenoSure Report--11-25-03.ai
©2003 Laboratory Corporation of America ® Holdings All Rights Reserved L890- 1103- 5 6170574201 1912 Alexander Drive Research Triangle Park NC, 27709 (800) 533- 0567 GENOTYPING REPORT Patient Information Routing Information Account Information / Age: Months Years Birth Date: Sex: SSN: Patient ID: SAMPLE, TEST Name / Initials: Visit: 10/ 31/ 2003 Reported: 10/ 23/ 2003...
author: harrelc
|
|
|
Approved Biotechnology Drugs, 2002
Biotechnology Information, Advocacy and Business Support | About Us | BIO Events | BIO Members | Join BIO | Member Services | Links | Home CMS Payment System Prescription Coverage & Reimbursement Food & Agriculture Industrial & Environmental Bioethics & Biomedical Research Intellectual Property Regulatory Policies Tax & Fiscal Policies All Issues & Initiatives Press Releases Company...
|
|
|
Prescription and Over-the-Counter Drug Product List: 7/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE TABLET; ORAL PROPOXYPHENE HCL AND ACETAMINOPHEN >A> AA VINTAGE PHARMS 650MG;65MG N40507 001 JUL 30, 2003 JUL NEWA ACYCLOVIR TABLET; ORAL ACYCLOVIR >D> AB CLONMEL HLTHCARE 400MG N74834 001 APR 24, 1997 JUL DISC >A> @ 400MG N74834 001 APR 24, 1997 JUL DISC >D> AB 800MG N74834 002 APR 24,...
author: AUTHOR
|
|
|
Fast Track Designated Products Approved since 1998
FAST TRACK DESIGNATED PRODUCTS APPROVED SINCE 1998 Through September 30, 2003 - NDA# NDA Drug Name Sponsor Applicant Approval Date Indication N020972 Sustiva (Efavirenz) 50/ 100/ 200MG Caps Dupont Pharms 9/17/98 Treatment of HIV N20977 Ziagen (Abacavir Sulfate) Tablets Glaxo Wellcome 12/17/98 Treatment of HIV N20978 Ziagen (Abacavir Sulfate) Oral Solution 12/17/98 N21007 Agenerase ...
author: Michael Lanthier
|
|
|
2004 Publications P-Z
In order for our site to display correctly you will need a newer version of your web browser.
Duodecim 120 (14): 1771-1777, 2004.
Structure (Camb ) 12 (3): 417-428, 2004.
Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, Howard S, Ribeiro R, Sandlund JT, Pui CH, Kaste SC.
Rong Y, Wang T, Morgan JI.
Preparation of a panel of avian influenza viruses of different...
author: St. Jude Children's Research Hospital
|
|
|
HIV Protocols / Clinical Studies
In order for our site to display correctly you will need a newer version of your web browser.
Opera v7 or higher (Windows, Linux) Apple's Safari (Mac OS X) Konqueror (Linux KDE Desktop) Microsoft Internet Explorer v6 or higher (Windows) or v5 or higher (Macintosh) Please note that this is not intended be an exhaustive list of browsers that support web standards, nor a test of...
author: St. Jude Children's Research Hospital
|
|
|
AT1021 Protocol / Clinical Study
Flynn, MD Infectious Diseases Children's Infection Defense Center (CIDC) Translational Trials Unit Pediatric HIV / AIDS - Protocol AT1021 Protocol / Clinical Study An Open-Label Study to Evaluate the Safety, Tolerance, Anti-Viral-Activity and Pharmacokinetics of Emtricitabine in Combination with Efavirenz and Didanosine in a Once Daily Regimen in HIV Infected...
author: St. Jude Children's Research Hospital
|
|
|
St. Jude Children's Research Hospital - Copyright 2003
AT1020 Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS 232632) in Combination Regimens in Antiretroviral Therapy (ART) Naive and Experienced HIV Infected Infants, Children and Adolescents For: HIV / pediatric AIDS AT1021 An Open-Label Study to Evaluate the Safety, Tolerance, Anti-Viral-Activity and Pharmacokinetics of Emtricitabine in...
author: St. Jude Children's Research Hospital
|
|
|
Infectious Diseases Protocols / Clinical Studies
In order for our site to display correctly you will need a newer version of your web browser.
The following browsers support numerous web standards including CSS, XHTML, and the DOM (a universal means of controlling the behavior of web pages): Netscape v7 or higher (all platforms), Mozilla FireFox (Windows), Camino (Mac OS X), Galeon (Linux GNOME Desktop) or other browser stemming...
author: St. Jude Children's Research Hospital
|
|
|
http://www.biosis.org/ts/media/cdjournals/gazettenews/2002/CPG_News_0224.pdf
week 0224 14 June 2002 Emtricitabine and lamivudine (right) are at the center of along running dispute involving Triangle Pharmaceuticals, GSK, Shire and Emory Univ that comes to a conclusion this week...
The same day saw the grant of SPC/GB02/001 to Aventis covering telithromycin.
Taking into account the product’s May 2000 approval, the pair will received a...
|
|
|
BioPortfolio Limited
Hepatitis B - New Kids on the Block TABLE OF CONTENTS CHAPTER 1 EXECUTIVE SUMMARY 3 Scope of the analysis 3 Datamonitor insight into the hepatitis B market 4 CHAPTER 2 PIPELINE DYNAMICS 16 The future HBV market is expected to consist mainly of NRTIs, with pipeline drugs expected to dominate the market 16 Pipeline overview 16 With the launch of up to eight compounds between 2005–...
|
|
|
Medivir: Medivir Science / HIV / Disease
HIV DISEASES CAUSED BY HIV Coming to terms with HIV/AIDS worldwide still requires very substantial resources.
In the rest of the world, some 5 million people have been infected with HIV, with 3 million AIDS deaths.
The HIV RT enzyme is analogous to a hand that the RNA chain is running through, and when this hand opens and closes, new building-blocks are joined into a strand of...
|
|
|
Contents Vol. 5, No. 3, 2004
3, 2004 Contents Review Article Lipid Peroxidation and Cataracts: N- Acetylcarnosine as a 125- 139 Therapeutic Tool to Manage Age- Related Cataracts in Human and in Canine Eyes MA Babizhayev, AI Deyev, VN Yermakova, IV Brikman, J Bours Original Research Assessment of the Safety and Efficacy of the Novel 141- 151 Article Tetrapeptide ITF- 1697 on Infarct Size after Primary PTCA in...
author: Adis International Limited
subject: Drugs in R and D
|
|
|
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal
Approved Active Moieties to which FDA has issued a Written Request for Pediatric Studies under Section 505A of the Federal Food, Drug, and Cosmetic Act NOTE: This list simply identifies approved active moieties to which FDA has issued a Written Request for pediatric studies since June 1998
Desflurane Baxter Healthcare Desloratadine Schering Dichlorphenamide Merck Didanosine...
|
|
|
http://www.adis.com/files/newsletters/INP/Icov1416.pdf
24 siRNAs: in vitro activity against SARS virus 8 CANCER Smallpox vaccine: prime- boost regimen improves safety 8 Abarelix (depot) approved in US for prostate cancer 22 WHO, UNAIDS release AIDS 3 by 5 strategy 2 Antineoplastics (neoadjuvant) in cervical cancer 16 Antineoplastics- based regimen in laryngeal preservation 15 MUSCULOSKELETAL DNA vaccine ± tretinoin in murine model...
|
|
|
Contents Vol. 63, No. 22, 2003
22, 2003 Contents Leading Article Advances in the Understanding and Treatment of 2379- 2394 Nonalcoholic Fatty Liver Disease SA Harrison, AM Di Bisceglie Review Article Drug Therapy for Adults with Attention- Deficit 2395- 2411 Hyperactivity Disorder TE Wilens Adis Drug Profile Emtricitabine: An Antiretroviral Agent for HIV infection 2413- 2424 LM Bang, LJ Scott ...
author: Adis International Limited
subject: Drugs
|
